Harnessing the Immune System to Fight Cancer

With the entry of immune checkpoint inhibitors such as anti-PD1 and anti-CTLA-4 into the clinic, excitement about immune-based therapies for cancer has been growing. Three immunologists at the Medical University of South Carolina (MUSC)—Zihai Li, M.D., Ph.D., Shikhar Mehrotra, Ph.D., and Chrystal Paulos, Ph.D.—discuss the promise of immune-based therapies such as immune checkpoint blockade and adoptive cell transfer and how the researchers and clinicians at MUSC are helping advance the field.

More at Progressnotes, MUSC’s Medical Magazine


Related Presenters

Zihai Li, MD, PhD.

Zihai Li, MD, PhD

Chairman and Professor Department of Microbiology & Immunology Program Leader Cancer Immunology Program Hollings Cancer Center Medical University of South Carolina (MUSC) Education Dr. Li received his medical degree from Henan Medical ...

View full profile

Chrystal Paulos, PhD.

Chrystal Paulos, PhD

Associate Professor Microbiology and Immunology Surgery 2004-2007  Postdoctoral Fellow,  Surgery Branch, NCI, NIH 2007-2011  Postdoctoral Fellow, University of Pennsylvania Education 2004  Ph.D. Purdue University

View full profile

Shikhar Mehrotra, PhD.

Shikhar Mehrotra, PhD

Associate Professor of Surgery PhD (Immunology) Sanjay Gandhi Post Graduate Institute of Medical Science & Research, Lucknow, India, 2001 Post-doctoral Fellow: Department of Medicine, University of Connecticut Health Center, 2001-2006 phone: ...

View full profile

Related Videos